Trial Profile
Efficacy of omalizumab in patients with chronic urticaria
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Nov 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- 19 Nov 2015 New trial record